Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice.

TitleNeuroprotective Effect of Progesterone in MPTP-Treated Male Mice.
Publication TypeJournal Article
Year of Publication2016
AuteursBourque, M, Morissette, M, Sweidi, SAl, Caruso, D, Melcangi, RC, Di Paolo, T
JournalNeuroendocrinology
Volume103
Issue3-4
Pagination300-14
Date Published2016
ISSN1423-0194
KeywordsAndrostane-3,17-diol, Animals, Autoradiography, Brain, Carbon Radioisotopes, Cocaine, Dihydrotestosterone, Disease Models, Animal, Dopamine, Dopamine Plasma Membrane Transport Proteins, Dose-Response Relationship, Drug, Drug Administration Schedule, Male, Mice, Mice, Inbred C57BL, MPTP Poisoning, Neuroprotective Agents, Progesterone, Testosterone, Vesicular Monoamine Transport Proteins
Abstract

BACKGROUND: Numerous studies have reported on the neuroprotective activity of estradiol, whereas the effect of the other ovarian steroid, progesterone, is much less documented.METHODS: This study sought to investigate neuroprotection with a low dose of progesterone (1 µg) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated male mice to model Parkinson's disease and compare it to the effect of this steroid in intact mice (experiment 1). We also investigated if high doses of progesterone could protect dopaminergic neurons already exposed to MPTP (experiment 2). We measured progesterone effects on various dopaminergic markers [dopamine and its metabolites, dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2)] and on neuroactive steroids in both plasma and the brain.RESULTS: For experiment 1, our results showed that progesterone completely prevented the effect of MPTP toxicity on dopamine concentrations, on the increase in the 3-methoxytyramine/dopamine ratio, as well as on VMAT2-specific binding in the striatum and the substantia nigra. Progesterone decreased MPTP effects on 3,4-dihydroxyphenylacetic acid concentrations and DAT-specific binding in the lateral part of the anterior striatum and in the middle striatum (medial and lateral parts). Progesterone treatment of intact mice had no effect on the markers investigated. For experiment 2, measures of dopaminergic markers in the striatum showed that 8 mg/kg of progesterone was the most effective dose to reduce MPTP effects, and more limited effects were observed with 16 mg/kg. We found that progesterone treatment increases the levels of brain progesterone itself as well as of its metabolites.CONCLUSION: Our result showed that progesterone has neuroprotective effects on dopaminergic neurons in MPTP-treated male mice.

DOI10.1159/000438789
Alternate JournalNeuroendocrinology
PubMed ID26227546
Grant ListMOP-82692 / / CIHR / Canada